These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 28195385

  • 1. Practical approaches to commencing device-assisted therapies for Parkinson disease in Australia.
    Williams DR, Evans AH, Fung VSC, Hayes M, Iansek R, Kimber T, O'Sullivan JD, Sue CM.
    Intern Med J; 2017 Oct; 47(10):1107-1113. PubMed ID: 28195385
    [Abstract] [Full Text] [Related]

  • 2. The Choice Between Advanced Therapies for Parkinson's Disease Patients: Why, What, and When?
    Dijk JM, Espay AJ, Katzenschlager R, de Bie RMA.
    J Parkinsons Dis; 2020 Oct; 10(s1):S65-S73. PubMed ID: 32651333
    [Abstract] [Full Text] [Related]

  • 3. Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation.
    Richter D, Bartig D, Jost W, Jörges C, Stumpe B, Gold R, Krogias C, Tönges L.
    J Neural Transm (Vienna); 2019 Jul; 126(7):879-888. PubMed ID: 31222604
    [Abstract] [Full Text] [Related]

  • 4. [Device-aided therapies in advanced Parkinson's disease].
    Timofeeva AA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016 Jul; 116(12):54-60. PubMed ID: 28139627
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Infusional Therapies, Continuous Dopaminergic Stimulation, and Nonmotor Symptoms.
    Mundt-Petersen U, Odin P.
    Int Rev Neurobiol; 2017 Jul; 134():1019-1044. PubMed ID: 28805563
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease.
    Antonini A, Nitu B.
    J Neural Transm (Vienna); 2018 Aug; 125(8):1131-1135. PubMed ID: 30006821
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy.
    Buhmann C, Hilker R, Lingor P, Schrader C, Schwarz J, Wolz M, Reichmann H.
    J Neural Transm (Vienna); 2017 Aug; 124(8):1005-1013. PubMed ID: 28229223
    [Abstract] [Full Text] [Related]

  • 12. The role of subcutaneous infusion of apomorphine in Parkinson's disease.
    Wenzel K, Homann CN, Fabbrini G, Colosimo C.
    Expert Rev Neurother; 2014 Jul; 14(7):833-43. PubMed ID: 24917215
    [Abstract] [Full Text] [Related]

  • 13. Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review.
    Volkmann J, Albanese A, Antonini A, Chaudhuri KR, Clarke CE, de Bie RM, Deuschl G, Eggert K, Houeto JL, Kulisevsky J, Nyholm D, Odin P, Østergaard K, Poewe W, Pollak P, Rabey JM, Rascol O, Ruzicka E, Samuel M, Speelman H, Sydow O, Valldeoriola F, van der Linden C, Oertel W.
    J Neurol; 2013 Nov; 260(11):2701-14. PubMed ID: 23287972
    [Abstract] [Full Text] [Related]

  • 14. Levodopa infusion therapies for Parkinson disease.
    Dean MN, Standaert DG.
    Curr Opin Neurol; 2024 Aug 01; 37(4):409-413. PubMed ID: 38780079
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry.
    Buongiorno M, Antonelli F, Cámara A, Puente V, de Fabregues-Nebot O, Hernandez-Vara J, Calopa M, Pascual-Sedano B, Campolongo A, Valldeoriola F, Tolosa E, Kulisevsky J, Martí MJ.
    Parkinsonism Relat Disord; 2015 Aug 01; 21(8):871-6. PubMed ID: 26003410
    [Abstract] [Full Text] [Related]

  • 18. Apomorphine in the treatment of Parkinson's disease: a review.
    Pessoa RR, Moro A, Munhoz RP, Teive HAG, Lees AJ.
    Arq Neuropsiquiatr; 2018 Dec 01; 76(12):840-848. PubMed ID: 30698208
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials.
    Lang AE, Rodriguez RL, Boyd JT, Chouinard S, Zadikoff C, Espay AJ, Slevin JT, Fernandez HH, Lew MF, Stein DA, Odin P, Fung VS, Klostermann F, Fasano A, Draganov PV, Schmulewitz N, Robieson WZ, Eaton S, Chatamra K, Benesh JA, Dubow J.
    Mov Disord; 2016 Apr 01; 31(4):538-46. PubMed ID: 26695437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.